PR Newswire | 25 Nov, 2015
MUMBAI: The Indian pharmaceutical industry is all set to experience the country's largest pharma event, CPhI and P-MEC 2015, in Mumbai. As a precursor to the event, during the week dedicated to the pharma industry, UBM will host the Indian edition of Pre-Connect Congress (7th edition internationally), India Pharma Awards and launch of Industry dedicated publication reports.
CPhI & P-MEC 2015, The Indian pharmaceutical market is growing at 13% annually, twice the world market growth rate. With 97 participating countries and over 1100 exhibitors and 32000 delegates, the three-day expo will provide a plethora of opportunities to international pharmaceutical companies to explore and benefit from. CPhI India is a sister brand of CPhI Worldwide.
Pre-Connect Congress would be a series of panel discussions among industry leaders, deliberating on topics related to M&A in pharma, regulatory issues and enhancing synergies, transition of India from a manufacturing hub to an innovation and drug discovery destination, pricing policy affecting profitability, technological advances and the biosimilars as the next booming segment for the Indian pharma market.
India Pharma Awards 2015 is a platform that recognizes innovation and celebrates excellence in the Indian pharma sector amidst a landscape wherein the industry is increasingly looking towards India for higher quality and low-cost pharma solutions. The UBM India Pharma Awards in association with TAKE Solutions as title sponsor will showcase organizational capabilities in the direction of innovations across 10 different categories and will be attended by the cream of industry, including policymakers from the country as well as Asia and Europe.
The India Pharma Exporters - Collector's Edition will felicitate the leading players for their noteworthy contribution to the Indian economy. The publication will include global and Indian trends of the Pharmaceutical industry covering production, demand - supply, export trends, investment, key growth drivers of the industry, government initiatives for the industry and future outlook. The World Of P-MEC will provide an overview of the industry, including global trends in P-MEC, P-MEC scenario in India, key growth drivers, investments and trends and future outlook.
Speaking on the much awaited week for pharma congregation in India, Mr. Yogesh Mudras, Managing Director, UBM India, said, "It is an exciting time for the pharma sector in India. The industry is setting itself on a growth trajectory and is expected to offer ample opportunities for the players in the sector. CPhI & P-MEC 2015 is well placed to provide an industry platform for every company that deals with pharmaceuticals in India. We have consistently received an overwhelming response from the participants and this year with the introduction of India Pharma Exporters - Collector's Edition & The World of P-MEC - Collector's Edition in addition to Pre-Connect Congress, we wish to bring in added insightful exchange amongst the industry veterans and stalwarts".
About UBM India
UBM India is India's leading exhibition organizer that provides the industry with platforms that bring together buyers and sellers from around the world, through a portfolio of exhibitions, content led conferences & seminars. UBM India hosts over 25 large-scale exhibitions and 40 conferences across the country every year; thereby enabling trade across multiple industry verticals. A UBM Asia company, UBM India has offices across Mumbai, New Delhi, Bangalore and Chennai. UBM Asia is owned by UBM plc, which is listed on the London Stock Exchange. UBM Asia is the leading exhibition organizer in Asia and the biggest commercial organizer in mainland China, India and Malaysia. For further details, please visit ubmindia.in.